{"id":"https://openalex.org/W4400272178","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.9587","title":"Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma.","display_name":"Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4400272178","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.9587"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.9587","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.9587","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.9587","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.9587","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.9587","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036227254","display_name":"Elizabeth M. Burton","orcid":"https://orcid.org/0000-0002-3424-4922","observed_orcids":["https://orcid.org/0000-0002-3424-4922"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth M. Burton","raw_affiliation_strings":["Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032190194","display_name":"Khalida Wani","orcid":"https://orcid.org/0000-0002-2383-3908","observed_orcids":["https://orcid.org/0000-0002-2383-3908"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khalida M. Wani","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111928597","display_name":"Den\u00e1i R. Milton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denai R. Milton","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039313430","display_name":"Rossana N. Lazcano Segura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rossana Lazcano Segura","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002241512","display_name":"Michael Tetzlaff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Tetzlaff","raw_affiliation_strings":["UCSF Dermatopathology Service, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Dermatopathology Service, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042127830","display_name":"Merrick I. Ross","orcid":"https://orcid.org/0000-0002-7787-0421","observed_orcids":["https://orcid.org/0000-0002-7787-0421"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Merrick I. Ross","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011325668","display_name":"Michael Andrew Postow","orcid":"https://orcid.org/0000-0002-3367-7961","observed_orcids":["https://orcid.org/0000-0002-3367-7961"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Postow","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103818472","display_name":"Isabella Claudia Glitza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabella Claudia Glitza","raw_affiliation_strings":["Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036199580","display_name":"Michael K.K. Wong","orcid":"https://orcid.org/0000-0002-4247-738X","observed_orcids":["https://orcid.org/0000-0002-4247-738X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael K.K. Wong","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030834372","display_name":"Adi K. Diab","orcid":"https://orcid.org/0009-0000-8944-1547","observed_orcids":["https://orcid.org/0009-0000-8944-1547","https://orcid.org/0000-0002-0153-0244"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adi Diab","raw_affiliation_strings":["Melanoma Medical Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Medical Oncology Department, University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081648218","display_name":"Jeffrey E. Gershenwald","orcid":"https://orcid.org/0000-0003-4519-5369","observed_orcids":["https://orcid.org/0000-0003-4519-5369"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey E. Gershenwald","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035218748","display_name":"Sapna Pradyuman Patel","orcid":"https://orcid.org/0000-0003-1339-1517","observed_orcids":["https://orcid.org/0000-0003-1339-1517"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sapna Pradyuman Patel","raw_affiliation_strings":["Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077265672","display_name":"Jennifer Leigh McQuade","orcid":"https://orcid.org/0000-0002-2393-2172","observed_orcids":["https://orcid.org/0000-0002-2393-2172"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Leigh McQuade","raw_affiliation_strings":["Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087156478","display_name":"Victor Gerardo Prieto","orcid":"https://orcid.org/0000-0001-9204-7161","observed_orcids":["https://orcid.org/0000-0001-9204-7161"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Gerardo Prieto","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002954478","display_name":"Charlotte Eielson Ariyan","orcid":"https://orcid.org/0000-0003-0818-3895","observed_orcids":["https://orcid.org/0000-0003-0818-3895"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charlotte Eielson Ariyan","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050445982","display_name":"Alexander J. Lazar","orcid":"https://orcid.org/0000-0002-6395-4499","observed_orcids":["https://orcid.org/0000-0002-6395-4499"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander J. Lazar","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035427219","display_name":"Jennifer Ann Wargo","orcid":"https://orcid.org/0000-0003-3438-7576","observed_orcids":["https://orcid.org/0000-0003-3438-7576"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Ann Wargo","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000768609","display_name":"Hussein A. Tawbi","orcid":"https://orcid.org/0000-0003-1942-851X","observed_orcids":["https://orcid.org/0000-0003-1942-851X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hussein A. Tawbi","raw_affiliation_strings":["Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029017725","display_name":"Rodabe Navroze Amaria","orcid":"https://orcid.org/0000-0001-6876-278X","observed_orcids":["https://orcid.org/0000-0001-6876-278X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodabe Navroze Amaria","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Melanoma Medical Oncology, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Melanoma Medical Oncology, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"9587","last_page":"9587"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8199999928474426},{"id":"https://openalex.org/keywords/relatlimab","display_name":"relatlimab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.5690000057220459},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.777999997138977},{"id":"https://openalex.org/keywords/resectable-melanoma","display_name":"resectable melanoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.8029999732971191},{"id":"https://openalex.org/keywords/pathological-response","display_name":"pathological response","score":0.6959999799728394},{"id":"https://openalex.org/keywords/major-pathologic-response","display_name":"major pathological response","score":0.7580000162124634},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.7239999771118164},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.7160000205039978},{"id":"https://openalex.org/keywords/ido1","display_name":"IDO1","score":0.7689999938011169},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.843999981880188},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6589999794960022},{"id":"https://openalex.org/keywords/tertiary-lymphoid-structures","display_name":"tertiary lymphoid structures","score":0.8730000257492065},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9249454736709595},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8488644361495972},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6108149290084839},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5364295840263367},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.5033981204032898},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4819219410419464},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4578160345554352},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36769813299179077},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1576957106590271},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.13101109862327576},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0829261839389801},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.9587","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.9587","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.9587","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.9587","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.9587","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.9587","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.9587","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.9587","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7799999713897705,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400272178.pdf","grobid_xml":"https://content.openalex.org/works/W4400272178.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388586239","https://openalex.org/W2981652925","https://openalex.org/W2898986397","https://openalex.org/W3021851930","https://openalex.org/W2800160190","https://openalex.org/W2890849069","https://openalex.org/W3004135494","https://openalex.org/W2947988614","https://openalex.org/W2605104598","https://openalex.org/W4388074844"],"abstract_inverted_index":{"9587":[0],"Background:":[1],"NST":[2,29,82],"with":[3,22,78,83,138,174,287,319,332,352,358,404],"immune":[4,355],"checkpoint":[5],"blockade":[6],"(ICB)":[7],"improves":[8],"clinical":[9,151,405],"outcomes":[10,334,406],"over":[11,328],"upfront":[12],"surgery":[13],"followed":[14],"by":[15],"adjuvant":[16],"treatment":[17],"(tx)":[18],"in":[19,115,281,296,384],"patients":[20,273],"(pts)":[21],"stage":[23],"III,":[24],"surgically":[25],"resectable":[26],"melanoma.":[27],"The":[28],"platform":[30],"also":[31,172],"provides":[32],"an":[33],"opportunity":[34],"for":[35,215,242,394],"deep":[36],"translational":[37],"analysis":[38,125,222,248,347],"to":[39,48,81,240],"identify":[40],"baseline":[41],"(BL)":[42],"biomarkers":[43],"predicting":[44],"pathologic":[45,79,106,185,253,360],"response":[46,80,107,361],"and":[47,69,128,136,153,168,182,223,234,276,309,330,373,379,402,409],"gain":[49],"insights":[50],"into":[51,180],"resistance.":[52],"BL":[53,127,247,295,316,354],"biomarkers,":[54],"including":[55,166],"gene":[56],"expression":[57,191,203,375],"signatures":[58,209],"(GES)":[59],"such":[60],"as":[61],"IFN-\u03b3/":[62],"tumor":[63,66,130],"mutational":[64],"burden,":[65],"infiltrating":[67],"lymphocytes,":[68],"presence":[70],"of":[71,113,365,376,399],"tertiary":[72],"lymphoid":[73],"structures,":[74],"have":[75,90],"been":[76],"associated":[77,318,357],"anti-PD1":[84],"and/or":[85],"anti-CTLA4":[86],"antibodies.":[87],"These":[88],"studies":[89],"not":[91],"evaluated":[92],"the":[93,150,158,225,232,245,260,282,343],"newest":[94],"ICB":[95],"combination,":[96],"nivo":[97],"(anti-PD1)":[98],"+":[99],"rela":[100],"(anti-LAG3),":[101],"which":[102],"achieved":[103],"a":[104,116,207,212,390],"major":[105,184,359],"rate":[108],"(MPR)":[109],"(\u226410%":[110],"viable":[111],"tumor)":[112],"63%":[114],"Ph":[117],"II":[118],"study":[119,135],"(NCT02519322).":[120],"Here":[121],"we":[122],"report":[123],"GES":[124,193,286,314,364],"from":[126,145,271,349],"longitudinal":[129,345,400],"tissues":[131],"obtained":[132],"on":[133,149,206,224,252],"this":[134,341],"correlations":[137,243,403],"outcomes.":[139],"Methods:":[140],"Longitudinal":[141],"tissue":[142],"was":[143,195,249,317],"collected":[144],"30":[146,261],"pts":[147,262,350,387],"treated":[148,351],"trial":[152,414],"available":[154],"RNA":[155,269,346],"analyzed":[156],"using":[157,197,211,231],"NanoString":[159],"nCounter":[160],"PanCancer":[161],"IO360":[162],"panel.":[163],"Clinical":[164,413],"outcomes,":[165],"recurrence":[167],"event-free":[169],"survival,":[170],"were":[171,178,218,279],"updated":[173],"longer":[175],"follow-up.":[176],"Pts":[177],"grouped":[179,250],"MPR":[181,255,297,386],"non-":[183],"responders":[186],"(non":[187],"MPR).":[188],"Normalization,":[189],"differential":[190],"/":[192],"evaluation":[194],"performed":[196],"nSolver":[198],"Advanced":[199],"Analysis":[200],"software.":[201],"Differential":[202],"is":[204,342],"fit":[205],"per":[208],"basis":[210],"linear":[213],"model":[214],"analysis.":[216,284],"P-values":[217],"adjusted":[219],"within":[220],"each":[221],"grouping":[226],"variable":[227],"level":[228],"difference":[229],"t-test":[230],"Benjamini":[233],"Yekutieli":[235],"False":[236],"Discovery":[237],"Rate":[238],"adjustment":[239],"account":[241],"amongst":[244],"tests.":[246],"based":[251],"response,":[254],"vs":[256,298],"non-MPR.":[257],"Results:":[258],"Of":[259],"(median":[263],"follow":[264],"up":[265],"44":[266],"months),":[267],"53":[268],"samples":[270,401],"26":[272],"(9":[274],"NR":[275],"17":[277],"R)":[278],"included":[280],"full":[283],"Immune":[285],"significantly":[288],"higher":[289,312,363,382],"(adjusted":[290],"p<":[291],"0.05)":[292],"differences":[293],"at":[294,315],"non-MPR":[299],"included:":[300],"B":[301,366],"cells,":[302,306,367,369,372],"CD45,":[303],"CD-8+":[304],"T":[305,371],"TIGIT,":[307,377],"IDO1,":[308],"IFN-\u03b3.":[310],"Significantly":[311],"B7-H3":[313,383],"non":[320,385],"MPR.":[321],"Additional":[322],"analyses":[323,398],"(i.e.,":[324],"cell":[325],"population":[326],"changes":[327],"time)":[329],"association":[331],"event":[333],"are":[335,407],"underway.":[336],"Conclusions:":[337],"To":[338],"our":[339],"knowledge,":[340],"first":[344],"reported":[348],"nivo+rela.":[353],"features":[356],"include":[362],"CD45+":[368],"CD8":[370],"increased":[374],"IDO":[378],"IFN-y.":[380],"Additionally,":[381],"may":[388],"indicate":[389],"clinically":[391],"actionable":[392],"strategy":[393],"further":[395],"evaluation.":[396],"Ongoing":[397],"underway":[408],"will":[410],"be":[411],"presented.":[412],"information:":[415],"NCT02519322":[416],".":[417]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}